FINVECTOR
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. They are authorised under EMA for the production of gene therapy products for clinical and commercial supply.
FINVECTOR
Industry:
Biotechnology
Address:
Kuopio, Eastern Finland, Finland
Country:
Finland
Website Url:
http://www.finvector.com
Total Employee:
101+
Status:
Active
Contact:
+4407795065336
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
Alimentary Health
Alimentary Health is a world leader in harnessing the power of the microbiome, discovering and developing probiotics.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Current Employees Featured
Official Site Inspections
http://www.finvector.com Semrush global rank: 9.07 M Semrush visits lastest month: 220
- Host name: thunder.cloudcity.fi
- IP address: 185.220.77.10
- Location: Finland
- Latitude: 60.1717
- Longitude: 24.9349
- Timezone: Europe/Helsinki
More informations about "FinVector"
About Us | FinVector - Our Inspiring Journey
FinVector is a dedicated partner in the fight against cancer. As an FDA-approved drug manufacturer, we work together with a meticulous attention to detail that ensures patient safety. We also possess a comprehensive understanding of …See details»
Careers | Welcome to our inclusive work community!
When you combine FinVector’s groundbreaking gene therapy work with Kuopio’s vibrant research ecosystem – bolstered by the esteemed University of Eastern Finland and its pioneering programs, along with FinVector’s new facility, which …See details»
FinVector - Crunchbase Company Profile & Funding
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Their state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have …See details»
FinVector | Scientist.com
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Our state-of-the-art facilities, highly experienced scientific team and commitment to …See details»
FinVector Oy - LinkedIn
FinVector ja Ferring Pharmaceuticals ovat avanneet eilen 3.10. uuden geeniterapian tuotantolaitoksen, Finportin, Kuopioon. Laitos on erikoistunut geeniterapian viruspohjaisen lääkeaineen ...See details»
FinVector Company Profile 2024: Valuation, Funding
FinVector General Information Description. Provider of research and development and cGMP manufacturing services of viral-based gene therapy products. The company offers services across a wide range of viral-based product types …See details»
FinVector - Contacts, Employees, Board Members, Advisors
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.See details»
FinVector pioneering cancer treatment, opens new facility
Oct 9, 2024 FinVector, a leading biopharmaceutical company, recently opened a state-of-the-art production facility to manufacture gene therapy products in Kuopio, Finland. The new Finport facility is set to become one of the world’s …See details»
Finvector - Products, Competitors, Financials, Employees, …
Finvector is a cGMP manufacturer of viral-based gene therapy products within the biopharmaceutical sector. The company provides production services for gene therapies …See details»
Science behind the company’s success - Finvector
The genesis of FinVector. The story of FinVector finds its origins in one of the world’s first gene therapy companies.. The tale of FinVector started in 1993 when Medigene Oy was founded in Finland with a mission to explore genetic …See details»
FinVector is a pioneer in its field - Business Kuopio
Aug 11, 2022 Home » FinVector is a pioneer in its field. FinVector is a pioneer in its field. 11.8.2022. FinVector is one of the world’s biggest manufacturers of viral-based gene therapy …See details»
FinVector - Funding, Financials, Valuation & Investors - Crunchbase
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
FinVector launched out from Kuopio into the world
Jan 18, 2018 FinVector has a 25-year history encompassing both ups and downs. The difficult times, however, have always been followed by recovery. In 2004, the company put the first …See details»
FinVector Company Profile - Office Locations, Competitors ... - Craft
FinVector is a company engaged in the research and development of gene and cell therapies. It provides cell banking and viral seed stocks, research and development, assay development …See details»
FinVector welcoming applications for cooperation and support for …
Nov 14, 2024 FinVector welcoming applications for cooperation and support for 2025. Gene therapies have the potential to profoundly impact the lives of patients and their families. Here …See details»
FinVector - Tech Stack, Apps, Patents & Trademarks - Crunchbase
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.See details»
finvector.com Reviews: Is this site a scam or legit?
Finvector.com Review. The Scam Detector website Validator gives finvector.com a medium-high trust score on the platform: 75.5. It signals that the business is best defined by the following …See details»
Newsroom - Finvector
FinVector acquires two plots of land from the City of Kuopio. Date 27.03.2024. Read more. FinVector and UEF to further intensify collaboration. Date 14.03.2024. Read more. Become a …See details»
Get in touch with us | Contact FinVector Oy
[email protected]. Employment-related questions For position-specific questions, please contact the person in the job ad. Please note that we cannot accept any job applications or similar …See details»